Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
13.18
+0.84 (6.81%)
Jun 5, 2025, 4:00 PM - Market closed
Capricor Therapeutics Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Capricor Therapeutics stock ranges from a low of $25 to a high of $77. The average analyst price target of $41.67 forecasts a 216.16% increase in the stock price over the next year.
Price Target: $41.67 (+216.16%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $30 | Buy | Reiterates | $30 | +127.62% | May 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $30 | Buy | Reiterates | $30 | +127.62% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +484.22% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +484.22% | Mar 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +484.22% | Mar 4, 2025 |
Financial Forecast
Revenue This Year
77.30M
from 22.27M
Increased by 247.08%
Revenue Next Year
101.66M
from 77.30M
Increased by 31.52%
EPS This Year
-0.49
from -1.15
EPS Next Year
-0.08
from -0.49
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 244.1M | 190.6M | 275.4M | ||
| Avg | 77.3M | 101.7M | 180.0M | ||
| Low | 5.9M | 25.4M | 66.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 996.2% | 146.6% | 170.9% | ||
| Avg | 247.1% | 31.5% | 77.1% | ||
| Low | -73.6% | -67.2% | -34.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.71 | 1.61 | 2.09 | ||
| Avg | -0.49 | -0.08 | 1.05 | ||
| Low | -1.87 | -1.25 | -0.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.